FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

703311000001108: Zyban 150mg modified-release tablets (GlaxoSmithKline) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16995501000001113 Zyban 150mg modified-release tablets (GlaxoSmithKline) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58189901000001115 Zyban 150mg modified-release tablets (GlaxoSmithKline UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zyban 150mg modified-release tablets (GlaxoSmithKline) Is a Bupropion hydrochloride 150mg m/r tablet false Inferred relationship Existential restriction modifier
Zyban 150mg modified-release tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zyban 150mg modified-release tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zyban 150mg modified-release tablets (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zyban 150mg modified-release tablets (GlaxoSmithKline) Has active ingredient Bupropion hydrochloride true Inferred relationship Existential restriction modifier
Zyban 150mg modified-release tablets (GlaxoSmithKline) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zyban 150mg modified-release tablets (GlaxoSmithKline) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zyban 150mg modified-release tablets (GlaxoSmithKline) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Zyban 150mg modified-release tablets (GlaxoSmithKline) Is a Zyban true Inferred relationship Existential restriction modifier
Zyban 150mg modified-release tablets (GlaxoSmithKline) Has specific active ingredient Bupropion hydrochloride true Inferred relationship Existential restriction modifier
Zyban 150mg modified-release tablets (GlaxoSmithKline) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Zyban 150mg modified-release tablets (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Zyban 150mg modified-release tablets (GlaxoSmithKline) Is a Bupropion 150mg modified-release tablets false Inferred relationship Existential restriction modifier
Zyban 150mg modified-release tablets (GlaxoSmithKline) Is a Bupropion 150mg modified-release tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zyban 150mg modified-release tablets (GlaxoSmithKline) 60 tablet 6 x 10 tablets Is pack of False Zyban 150mg modified-release tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Zyban 150mg modified-release tablets (GlaxoSmithKline) 60 tablet 6 x 10 tablets Has AMP True Zyban 150mg modified-release tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start